revision Clinical Modification. We con sidered the years before and after 2006 as "before" or "after" vaccine introduc tion. Data on HPV vaccine coverage, estimated by the National Institutes of Health based on the vaccination in the age group 13-17 years, were retrieved from the Centers for Disease Control Web site. 11 We included both sexes because, from the beginning of 2011, the Advi sory Committee on Immunization Prac tices has recommended the routine use of the quadrivalent (HPV) vaccine in young men and young women. We ana lyzed data on the rates of disease and vaccination considering the variation between calendar years in women of all ages and patients of both sexes 17 years of age and younger because these groups were most likely to be exposed to the HPV vaccine.
As shown in Figure A , there was no increase in hospitalizations after the introduction of the HPV vaccine, con sidering women of all ages. Similarly, there was no increase when we consid ered only patients 17 years of age and younger from the National Inpatient Sample and the Kids' Inpatient Sample ( Figure B) .
We carried out a further analysis of data from the Nationwide Emergency Department Sample for people admit ted to the emergency department with systemic lupus erythematosus as their first diagnosis. There was an increase in the number of emergency department admissions for women ( Figure A) . How ever, this appeared to apply only to older patients because it was not reproduced among those younger than 17 years ( Figure B) .
We could not obtain a reliable estimate of lupus hospitalization from the National Hospital Discharge Survey database because of the small number of patients who possibly had received the HPV vaccine. We found no evidence of an increase in the number of hospitaliza tions or emergency department admis sions because of lupus in patient groups exposed to HPV vaccine. This is consis tent with results from studies of patients receiving the HPV vaccine 4 In contrast, underweight people (BMI <18.5 kg/m 2 ) tend to report themselves heavier, resulting in a higher BMI com pared with measured BMI and an under estimation of underweight prevalence. 1 Less is known about biases in the estimate of mortality risk associated with these body weight categories using selfreported data. It has been shown that the mortality risk of obesity based on self report can be overestimated, ie, biased away from the null. 3, 4 Underweight is asso ciated with an increased mortality risk 5 and, because underweight persons tend to overestimate BMI, one might intuitively expect that the mortality risk of under weight based on selfreported BMI would be underestimated, ie, biased toward the null (the opposite of the effect in obese persons). Is that a misleading intuition?
Consider a cohort of 1000 men, of whom 10% were underweight at baseline, 70% had normal weight or were overweight, and 20% were obese, based on measured BMI. After 5 years, 36 men died (Table) . The relative risk (RR) of death was higher in underweight (RR = 2.0) and obese men (RR = 1.5) compared with that in normal weight and overweight men combined. We assumed that the mortality risk was higher in the lowest (<17.5 kg/m 2 ) category among underweight persons and in the highest BMI category (≥31 kg/m 2 ) among obese persons. Participants also reported their weight and height at baseline to com pute selfreported BMI. We assume that underweight men (measured BMI <18.5 kg/m 2 ) overestimated their BMI by 1 unit, on average. Consequently, men with measured BMI 17.5-18.4 kg/m 2 were classified as "normal weight" based on selfreported BMI, while in truth they were underweight (eAp pendix, eFigure, http://links.lww.com/ EDE/A735). Thus, using selfreported data, the prevalence of underweight was underestimated. Men with selfreported BMI <18.5 kg/m 2 had a measured BMI <17.5 kg/m 2 . Therefore, these men had a higher mortality compared with men with true BMI <18.5 kg/m 2 (8% vs. 6%). We assume that obese men under estimated their BMI by 1 unit, on aver age. Therefore, men with true BMI 30.0-31.0 kg/m 2 were classified as normal weight/overweight based on selfreported BMI although they were in truth obese. Using selfreported data, the prevalence of obesity was underestimated. Men with selfreported BMI ≥30.0 kg/m 2 had a mea sured BMI ≥31.0 kg/m 2 . Accordingly, they had a higher mortality compared with men with true BMI ≥30.0 kg/m 2 (6% vs. 4.5%). Using selfreported BMI to define body weight categories, the risk of under weight relative to normal/overweight was (4/50)/[(2 + 21 + 3)/(50 + 700 + 100)] = 2.6, which was higher than the RR (2.0) obtained with measured BMI. The RR of obesity was (6/100)/[(2 + 21 + 3)/(50 + 700 + 100)] = 2.0, which was also higher than the RR (1.5) obtained with measured BMI.
Although selfreports lead to an overestimation of BMI by underweight persons and an underestimation by obese persons, 1 the mortality (or disease) risk in both obese and underweight persons is likely overestimated when selfreported data are used to categorize people.
Our assumptions are simplistic. The errors in weight estimations depend on sex, age, and other characteristics, 2, 6 and the direction of the bias will depend on how people in the various catego ries estimate their weight. The possible effects of exposure misclassification on the estimation of RR are complex and barely generalizable. 7 Still, as shown, the effects of such misclassification can be counterintuitive. Direction and magnitude of bias should be evaluated carefully for each situation. 7 The over estimation of obesity risk based on self reports has been demonstrated 3, 4 and recently corroborated in a metaanaly sis. 8 Research is needed to confirm the bias entailed by defining underweight with selfreported data.
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Medicine (IUMSP) University Hospital Center of Lausanne Lausanne, Switzerland It should be noted that the NAD cost depends only on the cost through the ratio c 1 /c 0 (which can be easily seen by dividing both the numerator and the denominator by c 0 ). Even when not thinking in terms of cost, but requiring sensitivity to be x times more important than specificity, we can choose c 1 = x and c 0 = 1. It is also possible to choose c 1 and c 0 so that they sum to 1. 4, 5 Values for the NAD cost vary considerably when cost ratios c 1 /c 0 other than 1 are inves tigated (Table) . Finally, assuming equal cost (c = c 1 = c 0 ), the NAD cost simplifies to the NAD.
In summary, we recommend using the term "number allowed to diagnose" instead of "number needed to mis diagnose." Furthermore, we suggest including weights for sensitivity and specificity in the computations if there 
